BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20208978)

  • 1. Direct EPR Detection of Nitric Oxide in Mice Infected with the Pathogenic Mycobacterium Mycobacterium tuberculosis.
    Vanin AF; Selitskaya RP; Serezhenkov VA; Mozhokina GN
    Appl Magn Reson; 2010 Mar; 38(1):95-104. PubMed ID: 20208978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
    Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
    Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDR and Pre-XDR Clinical
    Fursov MV; Shitikov EA; Lagutkin DA; Fursova AD; Ganina EA; Kombarova TI; Grishenko NS; Rudnitskaya TI; Bespiatykh DA; Kolupaeva NV; Firstova VV; Domotenko LV; Panova AE; Vinokurov AS; Gushchin VA; Tkachuk AP; Vasilyeva IA; Potapov VD; Dyatlov IA
    Microorganisms; 2021 Aug; 9(8):. PubMed ID: 34442871
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium tuberculosis in C57BL/6 mice.
    Reddy MV; Luna-Herrera J; Daneluzzi D; Gangadharam PR
    Tuber Lung Dis; 1996 Apr; 77(2):154-9. PubMed ID: 8762850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Activities and Secretion of Cytokines Caused by Delamanid on Macrophages Infected by Multidrug-Resistant
    Lyu XL; Lin TT; Gao JT; Jia HY; Zhu CZ; Li ZH; Dong J; Sun Q; Shu W; Pan LP; Zhang ZD; Li Q
    Front Immunol; 2021; 12():796677. PubMed ID: 35003120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice.
    Scanga CA; Mohan VP; Tanaka K; Alland D; Flynn JL; Chan J
    Infect Immun; 2001 Dec; 69(12):7711-7. PubMed ID: 11705952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial or detrimental activity of regulatory T cells, indoleamine 2,3-dioxygenase, and heme oxygenase-1 in the lungs is influenced by the level of virulence of
    Lozano-Ordaz V; Rodriguez-Miguez Y; Ortiz-Cabrera AE; Hernandez-Bazan S; Mata-Espinosa D; Barrios-Payan J; Saavedra R; Hernandez-Pando R
    Front Cell Infect Microbiol; 2023; 13():1105872. PubMed ID: 37284503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice.
    Almeida FM; Ventura TL; Amaral EP; Ribeiro SC; Calixto SD; Manhães MR; Rezende AL; Souza GS; de Carvalho IS; Silva EC; Silva JA; Carvalho EC; Kritski AL; Lasunskaia EB
    PLoS One; 2017; 12(3):e0173715. PubMed ID: 28306733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis strains disrupted in mce3 and mce4 operons are attenuated in mice.
    Senaratne RH; Sidders B; Sequeira P; Saunders G; Dunphy K; Marjanovic O; Reader JR; Lima P; Chan S; Kendall S; McFadden J; Riley LW
    J Med Microbiol; 2008 Feb; 57(Pt 2):164-170. PubMed ID: 18201981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of chronic pulmonary tuberculosis in mice intravenously infected with ethambutol resistant Mycobacterium tuberculosis.
    Srivastava S; Ayyagari A; Dhole TN; Krishnani N; Nyati KK; Dwivedi SK
    Indian J Med Microbiol; 2008; 26(4):342-8. PubMed ID: 18974487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.
    Vilchèze C; Copeland J; Keiser TL; Weisbrod T; Washington J; Jain P; Malek A; Weinrick B; Jacobs WR
    mBio; 2018 May; 9(3):. PubMed ID: 29844114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insufficient Generation of Mycobactericidal Mediators and Inadequate Level of Phagosomal Maturation Are Related with Susceptibility to Virulent Mycobacterium tuberculosis Infection in Mouse Macrophages.
    Lee HJ; Ko HJ; Jung YJ
    Front Microbiol; 2016; 7():541. PubMed ID: 27148227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice.
    Dunn PL; North RJ
    Infect Immun; 1995 Sep; 63(9):3428-37. PubMed ID: 7642273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads.
    Ehlers S; Kutsch S; Benini J; Cooper A; Hahn C; Gerdes J; Orme I; Martin C; Rietschel ET
    Immunology; 1999 Nov; 98(3):313-23. PubMed ID: 10583588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis.
    Hirata T; Saito H; Tomioka H; Sato K; Jidoi J; Hosoe K; Hidaka T
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2295-303. PubMed ID: 8619585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced virulence of an extensively drug-resistant outbreak strain of Mycobacterium tuberculosis in a murine model.
    Smith KL; Saini D; Bardarov S; Larsen M; Frothingham R; Gandhi NR; Jacobs WR; Sturm AW; Lee S
    PLoS One; 2014; 9(4):e94953. PubMed ID: 24733050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes.
    López B; Aguilar D; Orozco H; Burger M; Espitia C; Ritacco V; Barrera L; Kremer K; Hernandez-Pando R; Huygen K; van Soolingen D
    Clin Exp Immunol; 2003 Jul; 133(1):30-7. PubMed ID: 12823275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.